Schedule 13G ownership disclosure

NEKTAR THERAPEUTICS

Common Stock, $0.0001 par value · CUSIP: 640268108

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SAMLYN CAPITAL, LLC

    Shares: 0.00 · Class: 0.0%

  • SAMLYN, LP

    Shares: 0.00 · Class: 0.0%

  • ROBERT POHLY

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-003241
Form type
SCHEDULE 13G/A
Filer
NEKTAR THERAPEUTICS
CIK
CIK 906709
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub